| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avalyn Pharma Inc. Common Stock (AVLN) has 5 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. AVLN is classified in the Biotechnology industry within the Healthcare sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.91M | $56.96M | +277.8K | |
| COO | 212.0K | $6.33M | - | |
| Dir | 27.0K | $805.0K | - | |
| Dir | 27.0K | $805.0K | - | |
| 10% | 0 | - | +555.6K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Sr One Capital Management, LLC52 | 10% Owner | Buy | 555,555 | $18.00 | $9,999,990.00 | +20.2% | |
| May 1, 2026 | Carroll Jill56 | Director | Buy | 277,778 | $18.00 | $5,000,004.00 | +14.6% |